149 related articles for article (PubMed ID: 3263717)
1. Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines in heart, adrenal gland, retina and caudate nucleus of the cat.
Ambrosio S; Blesa R; Mintenig GM; Palacios-Araus L; Mahy N; Gual A
Toxicol Lett; 1988 Nov; 44(1-2):1-6. PubMed ID: 3263717
[TBL] [Abstract][Full Text] [Related]
2. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Sirinathsinghji DJ; Whittington PE; Audsley AR
Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
[TBL] [Abstract][Full Text] [Related]
3. Peripheral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its main metabolite 1-methyl-4-phenylpyridinium ion (MPP+) in the rat.
Algeri S; Ambrosio S; Garofalo P; Gerli P
Eur J Pharmacol; 1987 Sep; 141(2):309-12. PubMed ID: 3500067
[TBL] [Abstract][Full Text] [Related]
4. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP.
Rose S; Nomoto M; Kelly E; Kilpatrick G; Jenner P; Marsden CD
Neurosci Lett; 1989 Jul; 101(3):305-10. PubMed ID: 2505199
[TBL] [Abstract][Full Text] [Related]
5. Effect of 4-(4-methoxy-1,2,5-thiadiazol-3-yl)-1-methyl-1,2,3,6-tetrahydropyridine , an analog of MPTP, on mouse heart norepinephrine and brain catecholamines.
Hemrick-Luecke SK; Mitch CH; Quimby SJ; Fuller RW
Neurochem Int; 1993 Nov; 23(5):467-70. PubMed ID: 8251928
[TBL] [Abstract][Full Text] [Related]
6. The influence of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the levels of dopamine, serotonin and their metabolites in the caudate nucleus of the rat.
Russ H; Henning K; Eckhardt H; Przuntek H
Arzneimittelforschung; 1985; 35(2):481-2. PubMed ID: 2581589
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys.
Di Paolo T; Bédard P; Daigle M; Boucher R
Brain Res; 1986 Aug; 379(2):286-93. PubMed ID: 2427166
[TBL] [Abstract][Full Text] [Related]
8. Depletion of cardiac norepinephrine but not brain catecholamines by MPTP-N-oxide in mice.
Hemrick-Luecke SK; Robertson DW; Fuller RW
Life Sci; 1990; 47(9):815-9. PubMed ID: 2215082
[TBL] [Abstract][Full Text] [Related]
9. Studies on the acute and long-term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Pileblad E; Carlsson A
Pharmacol Toxicol; 1988 Apr; 62(4):213-22. PubMed ID: 3260379
[TBL] [Abstract][Full Text] [Related]
10. Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats.
Chang GD; Ramirez VD
Brain Res; 1987 Oct; 424(1):49-57. PubMed ID: 3319041
[TBL] [Abstract][Full Text] [Related]
11. Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine affects the adrenal glands as well as the brain in the marmoset.
Fine A; Reynolds GP; Nakajima N; Jenner P; Marsden CD
Neurosci Lett; 1985 Jul; 58(1):123-6. PubMed ID: 3931004
[TBL] [Abstract][Full Text] [Related]
12. Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.
Cohen G; Pasik P; Cohen B; Leist A; Mytilineou C; Yahr MD
Eur J Pharmacol; 1984 Oct; 106(1):209-10. PubMed ID: 6442232
[No Abstract] [Full Text] [Related]
13. Effects of bifemelane on parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset.
Nomoto M; Irifune M; Fukuzaki K; Fukuda T
Neurosci Lett; 1994 Aug; 178(1):95-8. PubMed ID: 7816348
[TBL] [Abstract][Full Text] [Related]
14. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.
Schneider JS
J Neurosci Res; 1992 Jan; 31(1):112-9. PubMed ID: 1613817
[TBL] [Abstract][Full Text] [Related]
15. In vivo changes of catecholamines in hemiparkinsonian monkeys measured by microdialysis.
Skirboll S; Wang J; Mefford I; Hsiao J; Bankiewicz KS
Exp Neurol; 1990 Nov; 110(2):187-93. PubMed ID: 1699780
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of 1-ethyl- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridines on catecholamine concentrations in mouse brain and heart.
Fuller RW; Hemrick-Luecke SK; Robertson DW
Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):129-32. PubMed ID: 3258433
[TBL] [Abstract][Full Text] [Related]
17. Effects of L-deprenyl and amantadine in an MPTP-model of parkinsonism.
Rausch WD; Schallauer E; Chan WW; Riederer P; Weiser M
J Neural Transm Suppl; 1990; 32():269-75. PubMed ID: 1708404
[TBL] [Abstract][Full Text] [Related]
18. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on retinal dopaminergic system in mice.
Hamilton WR; Trickler WJ; Robinson BL; Paule MG; Ali SF
Neurosci Lett; 2012 May; 515(2):107-10. PubMed ID: 22414866
[TBL] [Abstract][Full Text] [Related]
19. Effects of nimodipine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced depletions in the biogenic amine levels in mice.
Gerlach M; Russ H; Winker J; Witzmann K; Traber J; Stasch JP; Riederer P; Przuntek H
Arzneimittelforschung; 1993 Apr; 43(4):413-5. PubMed ID: 7684224
[TBL] [Abstract][Full Text] [Related]
20. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF.
Elsworth JD; Deutch AY; Redmond DE; Sladek JR; Roth RH
Brain Res; 1987 Jul; 415(2):293-9. PubMed ID: 3496938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
